At Heart Matters, we go beyond being an information source – we share knowledge with genuine care. Empowering you with comprehensive, easy-to-understand insights.

Welcome to Heart Matters, your go-to destination for empowered heart health. Explore our comprehensive collection of articles, expert advice, and practical tips, designed to equip you with the knowledge and confidence to make positive changes. Discover the latest advancements in heart health research, learn about effective lifestyle modifications, and gain a deeper understanding of cardiac conditions and their treatments. Explore, learn, and join the Heart Matters community today.
Prof. Peter Barlis
Cardiologist & Founding Editor
At Heart Matters, we go beyond being an information source – we share knowledge with genuine care. Empowering you with comprehensive, easy-to-understand insights.
Stay informed with our up-to-date heart health insights. We cut jargon, providing empowering information for your cardiovascular well-being. Discover reliable resources that speak heart to heart, offering updated and accessible information.
Our blog articles have simplicity in mind, helping you understand key concepts. Stay updated with reliable information that speaks directly to you, empowering informed decisions about heart health.
We strive to offer dependable and updated insights, cutting through complex terminology to communicate effectively with you. Explore the advantages of reliable guidance that provides a clear perspective, supporting your journey towards knowledge and understanding.
Heart Matters provides essential information on heart health across six key platforms. We focus on heart disease risk factors, management, and prevention. Our goal is to make the information accessible and engaging, using simple language to explain complex concepts.
Our aim is to provide a holistic understanding of cardiovascular well-being and equip you with the knowledge and resources necessary to take control of your heart health journey.
Connecting you with the resources you need to be more informed.
Subscribe for practical tips and the latest research updates.
Expert insights on everything from prevention to intervention.
Bringing you conversations with doctors, researchers and more.
Cardiovascular risk factors include both modifiable and non-modifiable factors. Download our free blood pressure monitoring chart to track your readings for discussion with your healthcare provider.
Stay informed about cardiovascular health with our newsletter. Get the latest insights, valuable tips, expert advice, and educational content delivered straight to your inbox.
We understand that seeking reliable information about your heart can be overwhelming, and that’s why we’ve compiled a list of common questions and their answers to empower you with knowledge. Whether you want to learn about normal heart rates, blood pressure, heart disease risk factors, or heart-healthy lifestyle choices, we’ve got you covered. You can find additional information in the Resources secton by clicking here.
When first-line therapies for angina, such as beta blockers, calcium channel blockers, and nitrates, prove inadequate or are not well-tolerated, second-line therapies may be considered.
Perhexiline is a unique medication that enhances the heart's ability to utilize fatty acids for energy, reducing its reliance on oxygen and lowering oxygen demand. This action helps improve blood flow and alleviates chest pain in some patients with refractory angina.
Nicorandil is another second-line option with a dual mechanism of action. It opens potassium channels in smooth muscle cells, causing vasodilation and enhancing coronary blood flow. Additionally, nicorandil also stimulates nitric oxide release, further dilating blood vessels and reducing heart workload.
Trimetazidine is an anti-ischemic agent that improves cardiac efficiency by enhancing glucose metabolism and shifting the heart's energy production to a more oxygen-efficient process. As second-line therapies, these medications offer alternative approaches for managing angina in individuals who do not respond adequately to first-line treatments or those experiencing side effects from other medications.
Lipid-lowering therapies play a critical role in managing coronary artery disease (CAD), a condition characterized by the narrowing of blood vessels that supply the heart. Among the most commonly discussed and debated classes of medications are statins, which effectively reduce cholesterol levels and are widely prescribed to lower the risk of cardiovascular events. Alongside statins, other medications like ezetimibe, fibrates, and niacin are also utilized to target specific aspects of lipid metabolism, such as cholesterol absorption, triglyceride levels, and raising high-density lipoprotein (HDL) cholesterol. Additionally, the introduction of medications that inhibit PCSK9, an enzyme involved in cholesterol metabolism, has provided a promising new approach to further lower LDL cholesterol levels. These PCSK9 inhibitors, such as Repatha (evolocumab), have shown significant efficacy in reducing LDL cholesterol levels in patients with CAD, especially for those who may not respond well to traditional therapies.
Nitrates are widely used to treat angina and provide quick relief for chest pain. Commonly available in the form of sublingual sprays or tablets, patches, and long-acting tablets, nitrates work by dilating blood vessels, allowing for increased blood flow and reduced resistance. This dilation eases the heart's workload, leading to a decreased demand for oxygen and prompt alleviation of angina symptoms. Sublingual nitrates act rapidly and are often used to provide immediate relief during angina attacks, while patches and long-acting tablets are employed for preventive purposes. However, nitrates may cause side effects such as headaches, dizziness, and flushing, which usually subside over time.
Calcium channel blockers, including amlodipine, felodipine, cardizem (diltiazem), and verapamil, are commonly prescribed for the treatment of angina. These medications work by inhibiting the influx of calcium into the muscle cells of the heart and blood vessels, leading to their relaxation. As a result, blood vessels widen, promoting improved blood flow and reduced blood pressure. In the context of angina, this relaxation decreases the heart's workload, lowering the demand for oxygen and alleviating chest pain. Calcium channel blockers offer a valuable treatment option for individuals with angina, but it is essential to be aware of potential side effects, which may include headaches, dizziness, flushing, and ankle swelling.
Beta blockers, such as metoprolol, propranolol, atenolol, carvedilol, and bisoprolol, play a crucial role in treating angina. By blocking certain receptors in the heart, they effectively reduce heart rate and the force of contraction, thereby easing the heart's workload. This mechanism of action leads to a decreased demand for oxygen, making beta blockers highly effective in relieving chest pain associated with angina. As with any medication, it's important to consider potential side effects, including tiredness, worsened asthma, erectile dysfunction in some males, and more vivid dreams during sleep. Consult your healthcare provider to determine the suitability of beta blockers for managing your angina and overall heart health.
Anti-platelet medications play a crucial role in preventing blood clot formation, reducing the risk of serious cardiovascular events such as heart attacks and strokes. Among the widely used anti-platelet drugs are aspirin, clopidogrel, and ticagrelor.
Aspirin: This well-known medication inhibits platelet activation, making it less likely for platelets to stick together and form clots. Aspirin is commonly used for primary and secondary prevention of heart attacks and strokes.
Clopidogrel: As a potent anti-platelet agent, clopidogrel works by blocking specific receptors on platelets, preventing them from aggregating. It is often prescribed to patients with acute coronary syndrome, those undergoing stent procedures, and for some cases of peripheral arterial disease.
Ticagrelor: Ticagrelor is another effective anti-platelet drug that works by inhibiting platelet activation. It is used in acute coronary syndrome, often given alongside aspirin to reduce the risk of heart-related events.